Persistent paralysis after vecuronium administration.
Conway
E E
EE
D016638:Critical Illness; D006801:Humans; D009466:Neuromuscular Blocking Agents / Q000009:adverse effects; D010243:Paralysis / Q000139:chemically induced*; D014673:Vecuronium Bromide / Q000009:adverse effects*
D009466:Neuromuscular Blocking Agents; D014673:Vecuronium Bromide